Cargando…
P-148: Second booster BNT162b2 restores SARS-CoV-2 humoral response in patients with multiple myeloma, except for those under treatment with anti-BCMA agents
| Autores principales: | , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9403087/ http://dx.doi.org/10.1016/S2152-2650(22)00478-5 |
| _version_ | 1784773293134315520 |
|---|---|
| author | Ntanasis-Stathopoulos, Ioannis Karalis, Vangelis Gavriatopoulou, Maria Sklirou, Aimilia D Malandrakis, Panagiotis Migkou, Magdalini Roussou, Maria Fotiou, Despina Alexopoulos, Harry Eleutherakis-Papaiakovou, Evangelos Theodorakakou, Foteini Kastritis, Efstathios Trougakos, Ioannis P Dimopoulos, Meletios A. Terpos, Evangelos |
| author_facet | Ntanasis-Stathopoulos, Ioannis Karalis, Vangelis Gavriatopoulou, Maria Sklirou, Aimilia D Malandrakis, Panagiotis Migkou, Magdalini Roussou, Maria Fotiou, Despina Alexopoulos, Harry Eleutherakis-Papaiakovou, Evangelos Theodorakakou, Foteini Kastritis, Efstathios Trougakos, Ioannis P Dimopoulos, Meletios A. Terpos, Evangelos |
| author_sort | Ntanasis-Stathopoulos, Ioannis |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9403087 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Elsevier Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94030872022-08-25 P-148: Second booster BNT162b2 restores SARS-CoV-2 humoral response in patients with multiple myeloma, except for those under treatment with anti-BCMA agents Ntanasis-Stathopoulos, Ioannis Karalis, Vangelis Gavriatopoulou, Maria Sklirou, Aimilia D Malandrakis, Panagiotis Migkou, Magdalini Roussou, Maria Fotiou, Despina Alexopoulos, Harry Eleutherakis-Papaiakovou, Evangelos Theodorakakou, Foteini Kastritis, Efstathios Trougakos, Ioannis P Dimopoulos, Meletios A. Terpos, Evangelos Clin Lymphoma Myeloma Leuk Poster Presentations Elsevier Inc. 2022-08 2022-08-25 /pmc/articles/PMC9403087/ http://dx.doi.org/10.1016/S2152-2650(22)00478-5 Text en Copyright © 2022 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Poster Presentations Ntanasis-Stathopoulos, Ioannis Karalis, Vangelis Gavriatopoulou, Maria Sklirou, Aimilia D Malandrakis, Panagiotis Migkou, Magdalini Roussou, Maria Fotiou, Despina Alexopoulos, Harry Eleutherakis-Papaiakovou, Evangelos Theodorakakou, Foteini Kastritis, Efstathios Trougakos, Ioannis P Dimopoulos, Meletios A. Terpos, Evangelos P-148: Second booster BNT162b2 restores SARS-CoV-2 humoral response in patients with multiple myeloma, except for those under treatment with anti-BCMA agents |
| title | P-148: Second booster BNT162b2 restores SARS-CoV-2 humoral response in patients with multiple myeloma, except for those under treatment with anti-BCMA agents |
| title_full | P-148: Second booster BNT162b2 restores SARS-CoV-2 humoral response in patients with multiple myeloma, except for those under treatment with anti-BCMA agents |
| title_fullStr | P-148: Second booster BNT162b2 restores SARS-CoV-2 humoral response in patients with multiple myeloma, except for those under treatment with anti-BCMA agents |
| title_full_unstemmed | P-148: Second booster BNT162b2 restores SARS-CoV-2 humoral response in patients with multiple myeloma, except for those under treatment with anti-BCMA agents |
| title_short | P-148: Second booster BNT162b2 restores SARS-CoV-2 humoral response in patients with multiple myeloma, except for those under treatment with anti-BCMA agents |
| title_sort | p-148: second booster bnt162b2 restores sars-cov-2 humoral response in patients with multiple myeloma, except for those under treatment with anti-bcma agents |
| topic | Poster Presentations |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9403087/ http://dx.doi.org/10.1016/S2152-2650(22)00478-5 |
| work_keys_str_mv | AT ntanasisstathopoulosioannis p148secondboosterbnt162b2restoressarscov2humoralresponseinpatientswithmultiplemyelomaexceptforthoseundertreatmentwithantibcmaagents AT karalisvangelis p148secondboosterbnt162b2restoressarscov2humoralresponseinpatientswithmultiplemyelomaexceptforthoseundertreatmentwithantibcmaagents AT gavriatopouloumaria p148secondboosterbnt162b2restoressarscov2humoralresponseinpatientswithmultiplemyelomaexceptforthoseundertreatmentwithantibcmaagents AT sklirouaimiliad p148secondboosterbnt162b2restoressarscov2humoralresponseinpatientswithmultiplemyelomaexceptforthoseundertreatmentwithantibcmaagents AT malandrakispanagiotis p148secondboosterbnt162b2restoressarscov2humoralresponseinpatientswithmultiplemyelomaexceptforthoseundertreatmentwithantibcmaagents AT migkoumagdalini p148secondboosterbnt162b2restoressarscov2humoralresponseinpatientswithmultiplemyelomaexceptforthoseundertreatmentwithantibcmaagents AT roussoumaria p148secondboosterbnt162b2restoressarscov2humoralresponseinpatientswithmultiplemyelomaexceptforthoseundertreatmentwithantibcmaagents AT fotioudespina p148secondboosterbnt162b2restoressarscov2humoralresponseinpatientswithmultiplemyelomaexceptforthoseundertreatmentwithantibcmaagents AT alexopoulosharry p148secondboosterbnt162b2restoressarscov2humoralresponseinpatientswithmultiplemyelomaexceptforthoseundertreatmentwithantibcmaagents AT eleutherakispapaiakovouevangelos p148secondboosterbnt162b2restoressarscov2humoralresponseinpatientswithmultiplemyelomaexceptforthoseundertreatmentwithantibcmaagents AT theodorakakoufoteini p148secondboosterbnt162b2restoressarscov2humoralresponseinpatientswithmultiplemyelomaexceptforthoseundertreatmentwithantibcmaagents AT kastritisefstathios p148secondboosterbnt162b2restoressarscov2humoralresponseinpatientswithmultiplemyelomaexceptforthoseundertreatmentwithantibcmaagents AT trougakosioannisp p148secondboosterbnt162b2restoressarscov2humoralresponseinpatientswithmultiplemyelomaexceptforthoseundertreatmentwithantibcmaagents AT dimopoulosmeletiosa p148secondboosterbnt162b2restoressarscov2humoralresponseinpatientswithmultiplemyelomaexceptforthoseundertreatmentwithantibcmaagents AT terposevangelos p148secondboosterbnt162b2restoressarscov2humoralresponseinpatientswithmultiplemyelomaexceptforthoseundertreatmentwithantibcmaagents |